Q1 Earnings Estimate for BPMC Issued By Leerink Partnrs
Blueprint Medicines Co. (NASDAQ:BPMC – Free Report) – Leerink Partnrs issued their Q1 2025 EPS estimates for Blueprint Medicines in a research note issued on Thursday, February 13th. Leerink Partnrs analyst A. Berens forecasts that the biotechnology company will post earnings per share of ($0.77) for the quarter. The consensus estimate for Blueprint Medicines’ current […]
Blueprint Medicines Co. (NASDAQ:BPMC – Free Report) – Leerink Partnrs issued their Q1 2025 EPS estimates for Blueprint Medicines in a research note issued on Thursday, February 13th. Leerink Partnrs analyst A. Berens forecasts that the biotechnology company will post earnings per share of ($0.77) for the quarter. The consensus estimate for Blueprint Medicines’ current […]
